Dr Candace Day

Dr. Candace Day is a postdoctoral researcher in the Clinical and Health Sciences Academic Unit at The University of South Australia. Working at the interface between Academia and Industry, Candace is leading a variety of pharmaceutical based projects within the Pharmaceutical Innovation and Development Group (PIDG), supervised by Professor Sanjay Garg. Her current research directions include the development of novel human and veterinary pharmaceuticals for the treatment of various disorders, which engage with industrial collaborators.

Candace completed her Ph.D. with the thesis entitled "Novel functionalized mesoporous silica nanoparticles as targeted delivery systems to estrogen receptor-overexpressing breast cancer". Her value proposition is having experience with multidisciplinary research, including material sciences, synthetic chemistry (functionalised nanomedicines) and pharmaceutical formulation. Candace was also a demonstrator and a teaching assistant in undergraduate courses, including Drug Development and Dosage Form Design 4.  She now continues teaching in addition to conducting research.

Candace aims to introduce her innovative research intentions to world-renowned laboratories and universities in Australia and around the globe; ensuring that her ideas and passionate contributions in any means will be beneficial to the living kind.

Australasian Pharmaceutical Science Association (APSA) 

Member

Qualifications

• Doctor of Philosophy University of South Australia

• Bachelor of Biomedical Research (Honours) University of South Australia

• Bachelor of Pharmaceutical Science University of South Australia